Trials / Completed
CompletedNCT00343135
AUGMENTIN 1gm In Skin And Soft Tissue Infection
An Open, Non-comparative Study to Evaluate the Efficacy and Safety of AUGMENTIN 1gm (875mg Amoxicillin/125mg Clavulanic Acid) po q 12 Hours in the Treatment of Uncomplicated Skin and Soft Tissue Infections in Pakistan
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 195 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
Study to evaluate the effects of AUGMENTIN 1gm in the treatment of Skin and Soft tissue infections
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | amoxicillin/clavulanate potassium 1gm | amoxicillin/clavulanate potassium 1gm |
Timeline
- Start date
- 2004-12-01
- Primary completion
- 2005-03-01
- Completion
- 2005-03-01
- First posted
- 2006-06-22
- Last updated
- 2012-11-22
Locations
3 sites across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT00343135. Inclusion in this directory is not an endorsement.